NCT06488716 2025-12-24A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Terminated12 enrolled